Arbyn M, Anttila A, Jordan J et al. (Eds). (2008). European guidelines for quality assurance in cervical cancer screening, second edition. Chapter 3 pp.87-88. European Communities 2008. Available as www.screening.iarc.fr/doc/ND7007ENC_002.pdf
Albow R, Kitchener H, Gupta N, Desai M (2012). Cervical screening in England: the past, present, and future. Cancer cytopathol 120:87-96.
Arbyn M, Anttila A, Jordan J et al. (2010) European guidelines for quality assurance. Second edition - summary document. Ann Oncol 21:448-58.
Bogdanich W. Physician’s carelessness with Pap tests cited in procedure’s high failure rate. Wall Street Journal. November 2 1987;120.
Brindle G, Wakefield J, Yule R (1976). Cervical smears: are the right women being examined? BMJ i:1196-7.
Herbert A, Anshu, Gregory M, Gupta SS, Singh N (2009). Screen-detected invasive cervical cancer and its clinical significance during the introduction of organised screening. BJOG 116:854-59.
IARC working group on evaluation of cervical screening programmes (1986). Screening for squamous cervical cancer: duration of low risk after negative results of cervical cytology and its implication for screening policies. BMJ 293:659-64.
Lååra E, Day NE, Hakama M (1987). Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes. Lancet 329:1247-9.
Magregor JE, Moss SM, Parkin DM, Day NE (1985). A case-control study of cancer screening in north east Scotland. BMJ 290:1543-46.
Quinn M, Babb P, Jones J, Allen A on behalf of the United Kingdom Association of Cancer Registries (1999). Effect of screening on incidence of and mortality from cancer of the cervix in England: evaluation based on routinely collected statistics. BMJ;318:904-8.
Peto J, Gilham C, Fletcher O, Matthews FE (2004). The cervical cancer epidemic that screening has prevented in the UK. Lancet 364:249-56.
Andrae B, Andersson T M-L, Lambert PC et al. (2012). Screening and cervical cancer cures: population based cohort study. BMJ e900. Doi: 10.1136/bmj.e900.